Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11827663
SERIAL NO

17127979

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are UAP inhibitors to inhibit glucose flux in the hexosamine biosynthetic pathway and methods of treating a disease using the inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE JOHNS HOPKINS UNIVERSITYBALTIMORE MD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Quinones-Hinojosa, Alfredo Bel Air, US 23 15
Saeui, Christopher T Rockville, US 2 0
Shah, Sagar Ramesh Clemson, US 8 49
Yarema, Kevin J Woodstock, US 17 182

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 28, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 May 28, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 28, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00